Creative Planning Volitionrx LTD Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.39 - $2.6 $18,252 - $34,140	13,131 New	13,131 $31,000
Q1 2022 May 16, 2022	SELL	$2.41 - $3.24 $38,945 - $52,358	-16,160 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$3.01 - $3.78 $9,632 - $12,096	-3,200 Reduced 16.53%	16,160 $53,000
Q4 2020 Jan 29, 2021	BUY	$2.88 - $4.33 $4,619 - $6,945	1,604 Added 9.03%	19,360 $75,000
Q3 2020 Nov 05, 2020	BUY	$2.94 - $4.05 $7,514 - $10,351	2,556 Added 16.82%	17,756 $57,000
Q2 2019 Jul 26, 2019	BUY	$2.93 - $3.6 $5,860 - $7,200	2,000 Added 15.15%	15,200 $48,000
Q3 2017 Oct 17, 2017	BUY	$2.45 - $2.98 $32,340 - $39,336	13,200	13,200 $35,000

17.8M

41K

100

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $39M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.